產(chǎn)品搜索
相關(guān)文章
- 重磅!科學(xué)家成功利用免疫細(xì)胞運(yùn)輸抗癌藥物至腫瘤靶點(diǎn)
- CYP2C9基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 川大華西CRISPR研究再獲新進(jìn)展
- DKK-1細(xì)胞篩選模型
- 細(xì)胞株定期維護(hù)與監(jiān)測要做好哪些?
- 老靶點(diǎn)迭代突破創(chuàng)新:Her2靶點(diǎn)細(xì)胞模型
- 肥胖與腫瘤治療新星靶點(diǎn)——GDF15-GFRAL
- 血液系統(tǒng)惡性腫瘤治療研究熱點(diǎn)
- 耳聾基因檢測標(biāo)準(zhǔn)品
- 自身免疫疾病潛力靶點(diǎn)——IL-5藥篩細(xì)胞模型
聯(lián)系我們
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73294c-Kit_K642E-D816A/BaF3

- 詳細(xì)內(nèi)容
CBP73294 | |
I. Introduction | |
Cell Line Name: | c-Kit K642E-D816A/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
KIT K642E lies within the tyrosine kinase domain 1 (exon 13) of the Kit protein (PMID: 15990278). K642E results in constitutive phosphorylation of Kit and activation of downstream signaling (PMID: 15990278, PMID: 19802003), as well as transformation of cultured cells (PMID: 11073817). | |
III. Representative Data | |
1.Sanger of c-Kit K642E-D816A/BaF3 Figure 1. c-Kit_K642E-D816A/BaF3 K642E Figure 2. c-Kit K642E-D816A/BaF3 D816A | |
2. Anti-proliferation assay Figure 3. CTG Proliferation Assay of BaF3 c-KIT K642E/D816A (C5). | |
|